Hypertension and Mild Cognitive Impairment: State-of-the-Art Review
American Journal of Hypertension · 15.05.2024 · 37 (6) · 385-393
DOI: 10.1093/ajh/hpae007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Hypertension, online erschienen am 12.01.2024. Verfasst von Sultana Shajahan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain Health Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Hypertension, Antihypertensive Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Mid-life hypertension is associated with cognitive decline and dementia in later life. Reducing high blood pressure (BP) with antihypertensive agents is a well-researched strategy to prevent dementia and mild cognitive impairment (MCI). However, there is still limited direct evidence to support the approach, and particularly for the treatment of the very old and those with existing MCI. METHODS This review presents an overview of the current evidence for the relationship between MCI and hypertension, and of the potential pathophysiological mechanisms related to cognitive decline and incidence dementia in relation to aging. RESULTS Although observational data are near consistent in showing an association between mid-life hypertension and MCI and/or dementia, the evidence in relation to hypertension in younger adults and the very old (age >80 years) is much more limited. Most of the commonly available antihypertensive agents appear to provide beneficial effects in reducing the risk dementia, but there is limited evidence to support such treatment in those with existing MCI. CONCLUSIONS Further studies are needed to determine the optimal levels of BP control across different age groups, especially in adults with MCI, and which class(es) of antihypertensive agents and duration of treatment best preserve cognitive function in those at risk of, or with established, MCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Health Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
- Sydney School of Public Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
- Professorial Unit, The George Institute for Global Health, School of Public Health, Imperial College London, London, UK.
- Neurology Department, Royal Prince Alfred Hospital, Sydney Health Partners, Sydney, New South Wales, Australia.
Zitieren
APA
Shajahan, S., Peters, R., Carcel, C., Woodward, M., Harris, K., & Anderson, C. S. (2024). Hypertension and Mild Cognitive Impairment: State-of-the-Art Review. American Journal of Hypertension, 37(6), 385-393. https://doi.org/10.1093/ajh/hpae007
Vancouver
Shajahan S, Peters R, Carcel C, Woodward M, Harris K, Anderson CS. Hypertension and Mild Cognitive Impairment: State-of-the-Art Review. American Journal of Hypertension. 2024;37(6):385-393. doi:10.1093/ajh/hpae007
BibTeX
@article{Shajahan2024,
author = {Shajahan, Sultana and Peters, Ruth and Carcel, Cheryl and Woodward, Mark and Harris, Katie and Anderson, Craig S},
title = {Hypertension and Mild Cognitive Impairment: State-of-the-Art Review},
journal = {American Journal of Hypertension},
year = {2024},
volume = {37},
number = {6},
pages = {385--393},
doi = {10.1093/ajh/hpae007}
}
EUVIMED